Therapeutic for treating clostridium difficile infection

Abstract

The invention relates to deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a pharmaceutical or veterinary composition or formulation comprising at least deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a combination therapeutic comprising at least deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a method of treating a mammal suspected of being infected with, or infected with, C. difficile comprising the use of at least deoxyribonuclease; a method of cleaning or sterilizing a material or product comprising the use of at least deoxyribonuclease; and a cleaning or sterilizing product impregnated with or containing at least deoxyribonuclease.

Claims

1. A therapeutic composition for degrading Clostridium difficile biofilm, comprising a mammalian deoxyribonuclease or functional fragment thereof, and vancomycin, wherein the composition exhibits antibiotic activity against Clostridium difficile biofilm.

2. The therapeutic composition of claim 1, wherein said mammalian deoxyribonuclease is human, bovine, porcine, ovine, feline, canine, equine, or ungulate.

3. A method of cleaning or sterilising a material susceptible to colonisation by, or colonised with, Clostridium difficile, comprising applying to said material the Clostridium difficile therapeutic of claim 1.

4. The method according to claim 3, wherein said material is a plastics material.

Description

(1) The present invention will now be described by way of example only with particular reference to the following figures wherein:

(2) FIG. 1. Biofilm formation in cultures of different strains of Clostridium bacteria. Bacterial strains were grown under static or shaking conditions in rich liquid media (BHIS), with biofilms observed in cultures of both strains of C. difficile (630erm and R20291) but not C. perfringens. The appearance of the biofilms formed by the C. difficile isolates differed under static or agitated culture (FIGS. 1a& b);

(3) FIG. 2. SEM analysis of 630erm C. difficile biofilm formed in static culture. Biofilms formed in rich liquid media (BHIS) and non-rich liquid media (YP) under static culture conditions as shown by SEM. Biofilms in rich media are denser than the aggregates observed in YP media, with visible bacterial-matrix connections;

(4) FIG. 3. SEM analysis of 630erm C. difficile biofilm formed in agitated culture. Biofilms formed in rich liquid media (BHIS) and non-rich liquid media (YP) under agitated culture conditions as shown by SEM. Biofilms in rich media are denser than the aggregates observed in YP media, but there are no visible bacterial-matrix connections with bacteria occluded by the biofilm matrix;

(5) FIG. 4. SEM analysis of different Clostridium bacteria cultured on glass coverslips in rich (BHIS) or non-rich (YP) media. Bacteria adhere most effectively to the plastic compared to the glass, with bacteria-matrix connections dependent upon bacterial strain and media. Observed bacilli were longer for 630erm and R20291 in YP media compared to those BHIS media, with multifarious matrix connections. Spores were only observed in BHIS culture;

(6) FIG. 5. Confocal microscopy of 630erm C. difficile biofilm cultured in rich (BHIS) and non-rich (YP) media revealed C. difficile biofilms are composed of both nucleic acid and protein. Slides were stained with acridine orange (nucleic acid stain) and SYPRO Ruby (Protein stain). Both protein and nucleic acid are present in the biofilms, with a greater abundance of nucleic acid observed in both culture media;

(7) FIG. 6. C. difficile biofilms are mainly comprised of live bacterial cells. Confocal microscopy of 630erm and R20291 C. difficile biofilms cultured in rich (BHIS) media stained with syto9, which stains live cells green and propidium iodide which stains dead or dying cells red. The majority of bacteria appear as green and so are viable;

(8) FIG. 7. Biofilm produced by 630erm can be degraded with DNase, but not RNase or proteinase K. Cultures containing biofilm were treated with DNase, RNase or proteinase K for 15 minutes at the concentrations indicated. Biofilm was only degraded by DNase treatment;

(9) FIG. 8. Biofilm produced by R20291 strain can be degraded with DNase, but not RNase or proteinase K. Cultures containing biofilm were treated with DNase, RNase or proteinase K for 15 minutes at the concentrations indicated. Biofilm was only degraded by DNase treatment;

(10) FIG. 9. DNase inhibits formation of biofilms in liquid media. Addition of DNase (10 mg/ml) into the growth media inhibits the formation of biofilm for C. difficile strain 630Derm. Proteinase K (10 mg/ml) supplementation in the growth media, decreases biofilm formation in C. difficile strain 630Derm, compared to the untreated control. All samples were incubated statically for six days;

(11) FIG. 10. Confocal microscopy of 630erm C. difficile biofilms treated with DNase. Upon treatment of C. difficile biofilms with DNase the biofilm is degraded in a dose-dependent manner;

(12) FIG. 11. Confocal microscopy of 630erm C. difficile biofilms treated with varying concentrations of DNase. The degradation of the C. difficile biofilm was dose dependent, with incomplete digestion observed at 10 ug and more notably 1 ug DNase;

(13) FIG. 12. Disassembly of biofilms was investigated. In B. subtilis, certain D-amino acids and norspermidine have been shown to disassemble biofilms. These D-amino acids also prevented biofilm formation in E. coli and S. aureus and P. aeruginosa. A range of concentrations of the D-amino acids known to be effective against other bacteria were used.

(14) In B. subtilis biofilms have been disassembled with: 3 M D-tyrosine, 2 mM D-methionine, 5 mM D-tryptophan, 8.5 mM D-leucine, and then a mixture of each, (2.5 nM each D-amino acid above). In S. aureus films have been disassembled with 10 M, 100 M and 500 M D-phenylalanine, D-proline and D-tyrosine.
However, no significant effect was observed against C. difficile strains (upper) 630erm and (lower) R20291 when using 3 M D-tyrosine, 2 mM D-methionine, 5 mM D-tryptophan, 8.5 mM D-leucine, and then a mixture of each, (2.5 nM each D-amino acid above).
The graphs show that C. difficile biofilms are not disrupted by D-amino acids when tested in the same way the B. subtilis biofilms are disassembled.

(15) FIG. 13. Shows the effect of D-leucine on biofilm formation in C. difficile strains (upper) 630erm and (lower) R20291. Unfortunately, the growth of 630erm is inhibited in 50 mM D-leucine and reduced in R20291. Therefore we are not seeing biofilm disassembly at 50 mM, as there is no growth of the bacteria in strain 630erm to form a biofilm. At lower concentrations the amino acid appeared ineffective.

(16) FIG. 14. Shows the effect of D-tryptophan on biofilm formation in C. difficile strains (upper) 630erm and (lower) R20291. The graphs show that C. difficile biofilms are not disrupted by D-tryptophan.

(17) FIG. 15. Shows the effect of norspermidine on biofilm formation in C. difficile strains (upper) 630erm and (lower) R20291. Norspermidine has been shown to disassemble biofilms in B. subtilis at 100, 50 and 25 M. From the graphs it is clear that norspermidine does not disassemble biofilms in C. difficile at low concentrations, although there are strain dependent differences, 630erm biofilm level is significantly reduced p<0.05) in the 100 uM concentration of norspermidine, however, these biofilms developed in the presence of norspermidine, which may affect the growth rate at high concentrations. When the disassembly was performed in tissue culture flasks, the biofilm was not disrupted for 630erm.

(18) FIG. 16. Shows the effects of antimicrobial peptides on biofilm formation in C. difficile strains (light grey) 630erm and (dark grey) R20291.

(19) Disassembly by cationic peptidesBiofilm formation by P. aeruginosa, B. cenocepatia and L. monocytogenes has been shown to be prevented using a cationic peptide; further Human beta-defensin 3has been shown to inhibit biofilm formation in S. aureus. The two figures show that antimicrobial peptides 1 and 2 do not inhibit biofilm formation in C. difficile, and they do not disassemble biofilms. In fact, the concentration of antimicrobial peptide can actually enhance biofilm formation in C. difficile.

(20) FIG. 17. Shows the formation of biofilms in C. difficile can be prevented by the addition of alginate lyase. When 500 g and 1 mg of alginate lyase is added to the culture media the biofilm formation is inhibited.

(21) Table 1. shows bacterial strains and plasmids used in the study

METHODS

(22) Growth of Bacterial Strains

(23) C. difficile strains used in this study are summarised in table 1. Strains were stored at 80 C. and were cultured on Braziers agar containing 4% egg-yolk, C. difficile supplement and 1% defibrinated horse blood or BHIS media (BHIS Oxoid with 0.5% w/v yeast and 0.1% L-cysteine). Clostridium perfringens NCTC 8237 strain, the control positive for biofilm formation assay, was cultured in blood agar. Liquid cultures were grown in BHIS broth (broth heart infusion) plus yeast extract (0.5%) and L-Cysteine (0.1%) (BHIS) and yeast peptone (YP) broth, 16 gL.sup.1 peptone, 10 gL.sup.1 yeast, and 5 gL.sup.1 NaCl.sub.2. All cultures were grown in an anaerobic atmosphere (10% CO.sub.2, 10% H.sub.2, 80% N.sub.2) at 37 C. Escherichia coli strain CA434, the conjugation donor, was grown in Luria-Bertani (LB) broth or agar supplemented with 12.5 g/ml chloramphenicol.

(24) Biofilm Formation and Visualization

(25) C. difficile strains were grown on Brazier's agar for 2-3 days, and primary cultures were then inoculated using 3 single colonies into 10 ml pre-equilibrated BHIS and YP media. These were incubated for 16 h at 37 C., shaking at 65 r.p.m. These were inoculated with a 1/10 dilution into four different vessels to assess biofilm formation: a) Liquid cultures in tissue culture flasks. Primary cultures were inoculated 1/10 into duplicate secondary cultures, one was incubated for 6 days statically and the other for 6 days on a shaking platform at 65 rpm. Tissue culture flasks were removed from the anaerobe hood and photographs were taken. Figures were compiled using Adobe Photoshop elements 8.0. b) SEM and confocal Microscopy. For SEM, samples were processed from liquid cultures, in BHIS media, the supernatant removed carefully by pipetting, before 1 ml fixative (2.5% Paraformaldehyde/2.5% Glutaraldehyde/0.1 M Sodium cacodylate pH 7.4) was added. The YP samples were centrifuged for 1 min 30 sec at 1500 rpm to pellet the micro-aggregates, before 1 ml fixative (2.5% Paraformaldehyde/2.5% Glutaraldehyde/0.1 M Sodium cacodylate pH 7.4) was added. The samples were then processed in the microscopy unit, washed in 0.1 M Na cacodylate, post fixed in 1% osmium tetroxide/0.1 M Na cacodylate, then stored in MilliQ water over night at 4 C. These were then dehydrated in 30%, 50%, 70%, 80%, 90% and 100% Ethanol. The samples were then mounted onto the aluminium stub and air-dried prior to Sputter coating. For samples in 24 well plates, circular glass 13 mm coverslips were placed in low evaporation 24 well plates, after which 2 mls of BHIS/YP was carefully added. These were pre-equilibrated for 16 hours in an anaerobe chamber before inoculation with a 1/10 dilution from the primary cultures outlined about. The plates were sealed with Nescofilm and incubated for 6 days at 37 C. The media was then removed and the wells were washed with 700 l 1PBS. For SEM analysis, fixative (2.5% Paraformaldehyde/2.5% Glutaraldehyde/0.1 M Sodium cacodylate pH 7.4) was then added (500 l per well) and samples were processed as outlined above. Confocal microscopy glass 13 mm coverslips and Thermanox coated 13 mm coverslips were washed in the wells with 1PBS before 200 l of stain was applied and incubated according to the manufacturer's guidelines. The stains used were Acridine orange and FilmTracer SYPRO Ruby, Syto9 and Propidium iodide, and DAPI. These coverslips were mounted onto glass slides, a coverslip was applied over a 50% glycerol mounting media and these were sealed with clear nail varnish. The slides were visualised under oil immersion using a 40 objective using a laser confocal microscope. The excitation/emission used for these dyes were 488 nm/>560 nm respectively for SYPRO Ruby stain and 543 nm/>560 nm Acridine orange. Single stains of Syto9 and Propidium iodide were performed to control for any cross bleed between channels, before these were used in combination, the excitation/emission was 488 nm/505-550 nm for Syto9 and 543 nm/>650 nm for Propidium iodide. C. perfringens NTCT 8237 was used as positive control and the assays were performed in quadruplicate. Images were analysed using Zeiss LSM image browser, and the images were compiled in Adobe Photoshop elements 8.0 c) Crystal violet assay; BHIS and YP media was pre-equilibrated for 16 hours in low evaporation 24 well plates prior to inoculation, with a 1/10 dilution of the overnight primary cultures. Bacteria were grown statically in 2 mls of BHIS/YP in 24-well plates for 6 days at 37 C. To prevent evaporation plates were sealed with Nescofilm. The wells were then washed twice with 700 l 1PBS prior to incubation for 30 min at room temperature with 700 l of filter-sterilized 1% crystal violet. Excess crystal violet was removed from the wells, followed by two washes with 1PBS. The crystal violet was extracted by adding 700 l methanol to each well and incubated for 15 min at room temperature. The OD595 was measured in a Spectrophotometer. d) Glass tubes. BHIS/YP broth was added to glass tubes and pre-equilibrated for 16 hours prior to inoculation, with a 1/10 dilution of the overnight primary cultures. Samples were incubated for 6 days at 37 C., then removed from the anaerobe chamber and photographed. Images were compiled into figures using photoshop elements 8.0.
Degradation of the Biofilm

(26) DNase, RNase and proteinase K digests were performed to determine the constituents of the biofilms. Liquid cultures of 630erm and R20291 incubated for 3 and 6 days were then treated by the addition of Bovine DNase, final concentration 1 mg/ml and 100 g/ml, (10 mg stock dilutions were made in 0.15 M NaCl.sub.2). RNaseA was added to a final concentration of 1 mg/ml and 100 g/ml, (dilutions were made in nuclease free dH.sub.2O). Proteinase K was added to a final concentration of 1 mg/ml (stock 20 mg/ml). Samples were incubated at room temperature for 15 minutes. Before and after addition of the DNase/RNase or Proteinase K, images were taken using a Canon 600D SLR, using a 50 mm prime lens mounted on a lighting rig. These images were compiled in photoshop Elements 8.0. To determine if biofilm formation could be inhibited in liquid culture, primary cultures of 630erm and R20291 were diluted 1/10 into TC flasks containing a low concentration of DNase (10 g) or Proteinase K (10 g), these samples were incubated statically and with shaking for 6 days before images were captured as outlined above.

(27) DNase treatments were visualised by confocal microscopy; 630erm and R20291 were grown in 24 well plates for 6 days with thermanox coverslips, the media was removed and Bovine DNase was added to a final concentration of 1 mg, 100 g, 10 g and 1 g, after a 15 minute incubation the DNase was removed and slides were washed with 1 ml 1PBS. The untreated controls were incubated for 15 minutes with 0.15 M NaCl and washed with 1PBS. These coverslips were mounted onto glass slides, a coverslip was applied over a 50% glycerol mounting media and these were sealed with clear nail varnish. The slides were visualised under oil immersion using a 40 objective using a laser confocal microscope (Zeiss microscope).

(28) Disruption of Biofilm by D-Amino Acids, Norspermidine and Alginate Lyase.

(29) Liquid cultures of 630erm and R20291 incubated for 3 days in 12 and 24 well plates, were then treated by the addition of D amino acids, at 3 M D-tyrosine, 2 mM D-methionine, 5 mM D-tryptophan, 8.5 mM D-leucine, and then a mixture of each, (2.5 nM each D-amino acid above), Higher concentrations were also tested: D-leucine at 8.5 mM, 17 mM, 25 mM and, D-tryptophan at 5 mM, 10 mM, 25 mM and 50 mM. Norspermidine was also added into mature biofilm cultures (3 day old) at 15 M, 25 M, 50 M and 100 M. Antimicrobial peptides 1 and 2 were assessed for their ability to inhibit biofilm formation in 24 well plates, at a range of concentrations, 2.5 g/ml, 10 g/ml and 20 g/ml.

(30) Alginate lyase was added into mature biofilms (3 day old) at 500 g and 1 mg. The effects on biofilm formation were also assessed by the addition of the above chemicals into the media when the cultures were inoculated.

(31) Results

(32) Biofilm Formation in Liquid Culture

(33) Biofilm formation in C. difficile was assessed in different media under a range of conditions, including a variety of surfaces. The PCR ribotype 012 sequenced strain 630erm was analysed alongside the 027 PCR ribotype (R20291) and C. perfringens NCTC 8237. Strains were grown under static or shaking conditions in rich liquid media (BHIS) (FIG. 1) or non-rich media (YP) (FIG. 2) for 6 days. For C. difficile strains 630erm and R20291 biofilms were observed in BHIS broth in both shaking and static cultures, whereas for C. perfringens no obvious biofilms were observed and the media was turbid (FIG. 1). The appearance of the biofilms formed by the C. difficile isolates were distinctly different under the two different culture conditions analysed (FIGS. 1a & b). In static cultures the biofilm appear as a single distinct cloud like floc in a clear media (FIG. 1a), whereas in shaking cultures the biofilms appeared as multiple aggregates (FIG. 1a). The aggregates observed appear less dense in R20291 compared to 630erm, however the flocs and aggregates are not apparent in C. perfringens (FIG. 1). The biofilms observed in non-rich, YP broth were much smaller micro-aggregates (shaking conditions), and the flocs (static conditions) were apparent but not as stable as those formed in BHIS upon movement or agitation. The micro-aggregates were found predominantly attached to the side of the tissue culture flask under shaking conditions in the YP media (data not shown). Unlike other biofilm producing bacteria C. difficile does not form biofilms in glass tubes, termed pellicles, however sedimentation of the bacteria to the bottom of the tube was observed in both BHIS and YP media (data not shown).

(34) Visualisation of Biofilm by SEM

(35) SEM was used to visualise biofilm production in both liquid culture and attached to glass coverslips. Samples were analysed from both static cultures in BHIS and YP media (FIGS. 2a and b), as well as shaking cultures in both media (FIGS. 3a and b). The 150 magnification revealed the difference in density of the biofilms in BHIS compared to YP media in both shaking (FIGS. 2a/b panel 1) and static (FIGS. 3a/b panel 1) conditions. The biofilms formed in BHIS are larger and denser than the biofilms formed in YP media, which are visible as micro-aggregates. The 3000 magnification allows visualisation of the bacterial community and the matrix structure under static conditions for BHIS (FIG. 2a panel 2) and YP media (FIG. 2b panel 2), whereas under shaking conditions structure of the biofilms appear different. The individual bacteria are occluded by the density of the matrix in both BHIS (FIG. 3a panel 2 and 3) and YP shaking conditions (FIG. 3b panel 2 and 3). At 10,000 magnification the individual bacteria and their matrix connections are clearly visible in both BHIS (FIG. 2a, panel 3) and YP media (FIG. 2b, panel 3) in static culture. The filament connections between the bacteria and matrix are more apparent in BHIS media compared to YP (FIG. 2, panel 3). However, under shaking conditions, the 10,000 magnification reveals the individual bacteria and their matrix connections are not visible (FIGS. 3a/b, panel 3).

(36) The biofilms formed on glass cover slips were reduced (FIG. 4) compared with those formed in liquid media (FIGS. 1 and 2). The biofilms appeared to attach more efficiently to the plastic well in which the coverslips were incubated for 6 days, rather than to the glass coverslips. SEM images at 10,000 magnification reveal the matrix and bacteria are clearly visible in both BHIS (FIGS. 4a-c) and YP (FIGS. 4d-f) media; however there appear to be media specific and strain specific differences in the structure of the matrix and the bacteria. On glass coverslips the matrix appears multifarious for 630erm and R20291 in YP media (FIGS. 4d and e respectively) compared to BHIS (FIGS. 4a and b respectively). The bacteria appear to be longer for both 630erm (FIGS. 4a/d) and R20291 (FIGS. 4b/e) in YP media compared to the bacteria observed in BHIS media. Spores are present in R20291 BHIS (FIG. 5) at approximately 1-2 uM in size, and there is less visible matrix in this sample. The biofilms produced by C. perfringens also appear different in the various media; in BHIS media the majority of the sample is formed of coccoid shapes, with few rod shaped bacteria (FIG. 4c), whereas in YP media the majority of the sample is comprised of rod shaped bacteria joined by matrix (FIG. 4f). The matrix produced by C. perfringens is visually different from the matrix produced by C. difficile (FIGS. 4d/e).

(37) Visualisation of Biofilm Using Confocal Microscopy

(38) Confocal microscopy with nucleic acid and protein specific stains was used to visualise the matrix produced by the C. difficile strain 630erm, and determine the constituents. Strain 630erm was grown for 6 days in 24 well plates containing glass coverslips in both BHIS and YP media. These coverslips were stained using Acridine orange (specific to nucleic acid) and SYPRO Ruby (specific to proteins), then visualised by confocal microscopy (FIG. 5). The confocal images revealed that the EPS matrix formed by 630erm was comprised of both proteins (FIGS. 5a/5c) and nucleic acid (FIGS. 5b/5d), however the majority of the EPS matrix stained with the nucleic acid specific stain Acridine orange (FIGS. 5b/5d). Once again consistent visual differences of the biofilms formed in BHIS media (FIGS. 5a/5b) compared to YP (FIGS. 5c/5d) were apparent. In BHIS media the biofilms are larger in diameter and more spread out than those formed in YP media (FIGS. 5a-b, 4c-d respectively). To determine the proportion of live and dead bacteria in the EPS matrix, a live-dead stain was performed with propidium iodide and syto9 which revealed the majority of the matrix was comprised of live bacteria for both 630erm (FIG. 6a) and R20291 (FIG. 6b).

(39) Composition and Degradation of the EPS Matrix

(40) Confocal microscopy staining revealed that the majority of the matrix stained with the nucleic acid stain Acridine orange rather than the protein stain SYPRO Ruby. To determine whether this was consistent with the constituents of the EPS matrix, digests with DNase, RNase A and proteinase K, were performed on the flocs produced in static culture by 630erm (FIG. 7). Degradation of the biofilm was observed in flask 2 and 3 (FIG. 7), which correspond to a 15 minute treatment with 1 mg/ml and 100 ug/ml DNase respectively, compared to Flask 1 the untreated control. RNase digestion of the floc produced by 630erm did not disrupt the biofilm at 1 mg/ml or 100 ug/ml flasks 4 and 5 (FIG. 7). A partial degradation with proteinase K was not observed (FIG. 7 flask 6) until the concentration was increased to 2 mg/ml proteinase K or the incubation time was increased to 24 hours (data not shown). The treatment with DNase, RNase A and proteinase K was reproducible with strain R20291 (FIG. 8), with degradation of the biofilm observed with both 1 mg/ml and 100 mg/ml DNase.

(41) Inhibition of biofilm formation in TC flasks was performed by the addition of a low concentration of DNase (10 g/ml) prior to inoculation of the media (FIG. 9). After a 6 day incubation under static and shaking conditions the media was turbid, indicating bacterial growth, but no flocs or aggregates were observed. This was compared to the untreated control and a low concentration of proteinase K (10 g/ml) added prior to inoculation, in which flocs and aggregates were observed. However the flocs and aggregates observed in the media containing proteinase K, appeared smaller in the case of the aggregates and less dense in the case of the floc than those in the untreated control (FIG. 9).

(42) Visualisation of the DNase Treatment by Confocal Microscopy

(43) Strains 630erm and R20291 were grown in 24 well plates on both glass and thermanox coverslips (plastic coated). Biofilm formation was superior on the thermanox coverslips in both BHIS and YP media (FIG. 10). Degradation of the biofilms was performed by incubating the coverslips in the 24 well plate with DNase for 15 minutes before visualisation by confocal microscopy. The biofilms were absent in the DNase treatment for both BHIS (FIG. 10b) and YP media (FIG. 10d), compared to the untreated controls (FIGS. 10a and 10c). The z-stack produced with the controls reveals that the biofilm formed in BHIS (FIG. 10a) is thicker in YP media (FIG. 10c). This observation was reproduced in strains R20291 (data not shown). The degradation of the C. difficile biofilm was dose dependent, whereby at 10 ug (FIG. 11c) and more notably 1 ug DNase (FIG. 11d), incomplete degradation of the biofilm was observed.

(44) Use of Agents to Degrade Biofilm

(45) Additional compounds were assessed for their ability to disrupt and inhibit biofilm formation. The effects of certain D-amino acids on the integrity and formation of biofilm formation was assessed using a wide variety of concentrations. At low concentrations the biofilm formation and stability was unaffected by D-amino acids tested (FIG. 12). The effects of high concentrations of D-amino acids were to increase the biofilm formation (FIG. 13), with the exception of 50 mM in strain 630erm, as this concentration completely inhibited growth by disassembling the preformed biofilms. D-tryptophan also increased the biofilm formation in strain R20291 at all concentrations tested, and at high concentrations in strain 630erm (FIG. 14). Norspermidine and D-amino acids are produced naturally by B. subtilis to disassemble biofilms, however, the addition of norspermidine to biofilm cultures actually enhances the biofilm formation in the hypervirulent outbreak strains R20291. There is a slight decrease in viability in strain 630erm at the highest concentration of norspermidine (FIG. 15). This indicates that there are strain dependent differences to the treatment with D-amino acids and norspermidine, however, none of these successfully disrupt the C. difficile biofilm. Antimicrobial peptides are cationic peptides, which have been shown to disrupt DNA, however, when such peptides were tested against C. difficile (FIG. 16) the effect was to enhance rather than inhibit the formation of the biofilm. The effect of alginate lyase on inhibiting and disrupting biofilm formation was also assessed. It is clear that alginate lyase can inhibit biofilm formation in strains R20291 and 630erm, however, it does not break down existing mature biofilms (FIG. 17).

SUMMARY

(46) The main findings of this study can be summarised as follows:

(47) We have unequivocally demonstrated that C. difficile form biofilms in vitro in both liquid broth and on surfaces. Through evaluation of biofilm formation in numerous C. difficile clinical isolates, we have shown that the bacteria and the extracellular polymeric substance (EPS) matrix comprising the biofilm are clearly visible by both scanning electron microscopy and confocal microscopy. The super-structure and sub-structures of these biofilms and their compositions differ dependent upon the strain of bacteria and environmental conditions, such as nutrient availability and the specific growth parameters. Notably, unlike some bacteria, our evidence shows C. difficile are most likely to form biofilms in nutrient rich conditions, and matrix formation may therefore represent a mechanism to avoid sporulation in order to colonise a host before the transmission phase of the infection.

(48) We have found that in both rich and non-rich media C. difficile biofilms are formed primarily of nucleic acid, polysaccharides, and proteins. Importantly, however, we have found that under all conditions tested the major component of the EPS matrix is nucleic acid, namely DNA, combined with some protein. Furthermore, we have shown that the biofilm of C. difficile is disrupted in a dose dependent manner by DNase treatment, whereas RNase A and proteinase K digestion have less effect on the biofilm structural integrity. Unlike some bacteria, a large proportion of the biofilm is comprised of live bacteria.

(49) C. difficile biofilms are heterogenous and comprise live bacteria. These properties contribute to the virulence of the disease.

(50) Bacterial biofilms can be disrupted by a number of different compounds, depending on the bacteria and the components of the matrix. It has been shown that B. subtilis produces D-amino acids and norspermidine to target components of the biofilm, and to promote dispersal of the biofilm, however when these compounds are tested in C. difficile, they have little or no effect on biofilm formation or the dispersal of the C. difficile biofilm. Antimicrobial peptides have also been shown to have an inhibitory effect on biofilm formation; however it appears that the antimicrobial peptides tested against C. difficile actually enhance biofilm formation at sub-inhibitory concentrations.

(51) Alginate lyase has been shown to inhibit biofilm formation in pseudomonas aeruginosa (Alkawash et al) and it has been proposed that P. aeruginosa produce alginate lyase to promote biofilm dispersal, by dispersal of the exopolysaccharide (alginate). It was thought that this dispersal was an enzymatic degradation, however, there is a recent paper that suggests alginate lyase disrupts biofilms in a catalyse independent manor (Lamppa et al.,). It is unclear whether C. difficile biofilms are comprised of alginate. However, the addition of alginate lyase to the culture medium prevents the formation of these biofilms, but does not disrupt mature biofilms.

(52) Notably, specific degradation of C. difficile biofilm by DNase treatment in a dose dependent manner provides a method by which the virulence of the bacteria can be reduced, limiting its ability to colonize the host to cause infection and also improves its susceptibility to other cytotoxic compounds. This therefore represents a new clinical avenue and potential therapeutic target in the treatment of C. difficile infection.

(53) TABLE-US-00001 TABLE 1 Strains Characteristics Source 630erm An erythromycin derivative of C. difficle Hussain et 630, PCR ribotype 012 al., 2005 R20291 Hypervirulent PCR ribotype 027, isolated Stabler et al., from an outbreak in 2004-2004 2009 C. perfringens strain NCTC 8237 Peter Donachie

REFERENCES

(54) Flemming, H. C. & Wingender, J. (2010) The biofilm matrix. Nat Rev Microbiol. 8(9): 623-33. Reynolds, C. B, Emerson, J. E., de la Riva, L., Fagan, R. P. & Fairweather, N. F. (2011) The Clostridium difficile Cell Wall Protein CwpV is Antigenically Variable between Strains, but Exhibits Conserved Aggregation-Promoting Function. PLoS Pathogens, 7(4): e1002024. Rupnik, M., Wilcox, M. H. & Gerding, D. N. (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 7: 526-536. Lamppa J W, Griswold K E: Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergy. Antimicrob Agents Chemother 2013, 57(1):137-145. Alkawash M A, Soothill J S, Schiller N L: Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 2006, 114(2):131-138.